Drug Type Small molecule drug |
Synonyms MU 1700, MU1700 |
Target |
Action inhibitors |
Mechanism ALK1 inhibitors(Activin receptor-like kinase 1 inhibitors), ALK2 inhibitors(Activin receptor type-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H22N4O |
InChIKeyFFLJVBPCONQSQW-UHFFFAOYSA-N |
CAS Registry3055312-41-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Preclinical | Germany | 18 Jul 2024 |





